Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
Hatem M Marey, Amin F EllakwaDepartment of Ophthalmology, Faculty of Medicine, Menoufiya University, Shibin el Kom, EgyptPurpose: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP) control in neovascular glaucoma.Methods: A re...
Main Authors: | Marey HM, Ellakwa AF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-06-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/intravitreal-bevacizumab-with-or-without-mitomycin-c-trabeculectomy-in-a7712 |
Similar Items
-
Effect of Preoperative Intravitreal Bevacizumab on the Success of Trabeculectomy with Mitomycin C in Neovascular Glaucoma
by: Fuad Ahmad Khan Niazi
Published: (2015-06-01) -
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
by: Marey HM, et al.
Published: (2011-07-01) -
Pre-trabeculectomy intravitreal injections of Bevacizumab for treating neovascular glaucoma in diabetic patients
by: Marjanović Ivan, et al.
Published: (2020-01-01) -
Effects of intravitreal injection of Bevacizumab combined with complex trabeculectomy for advanced neovascular glaucoma
by: Qing-Wei Du, et al.
Published: (2015-10-01) -
Trabeculectomy combined with mitomycin and retinal condensation for neovascular glaucoma
by: Yue-Sheng Qiu, et al.
Published: (2016-04-01)